Beta Drugs Ltd.

The total asset value of Beta Drugs Ltd. stood at ₹ 205 Cr as on 31-Mar-23

The share price of Beta Drugs Ltd. is ₹1,329.05 (NSE) as of 11-Dec-2023 IST. Beta Drugs Ltd. has given a return of 126.48% in the last 3 years.

Beta Drugs Ltd. has a market capitalisation of ₹ 1,278 Cr as on 11-Dec-2023. As per Value Research classification, it is a Small Cap company.

The P/B ratio of Beta Drugs Ltd. is 10.40 times as on 11-Dec-2023, a 1.93% premium to its peers’ median range of 3.55 times.

The P/E ratio of Beta Drugs Ltd. is 41.59 times as on 11-Dec-2023, a 0.35% premium to its peers’ median range of 30.74 times.

Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Beta Drugs Ltd. and enter the required number of quantities and click on buy to purchase the shares of Beta Drugs Ltd..

The promoter of Beta Drugs Ltd. is Neeraj Batra. Neeraj Batra owns 65.96 per cent of the total equity. The chairman of the company is Rahul Batra , and the managing director is Rahul Batra..

The promoters of Beta Drugs Ltd. have pledged 0% of the total equity as on Sep-23.

Some of the close peers are:

Yes, TTM profit after tax of Beta Drugs Ltd. was ₹31 Cr.